Mussaenda frondosa leaf powder in treating Dandruff

A Pharmaco-therapeutic evaluation of Mussaenda frondosa Linn. leaf in Darunaka w.s.r to its antifungal activity on Malassezia species. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/074221

Enrollment

Registered

2024-09-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L210- Seborrhea capitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex will be taken for the study. Patients between the age group of 18 — 40 years of age. Patient diagnosed with Darunaka

Exclusion criteria

Exclusion criteria: Patients suffering from chronic systemic diseases. Auto immune disorders of skin. Allergic manifestations. Psychological disorders. History of infectious disorders.

Design outcomes

Primary

Measure	Time frame
To find the effect of Mussaenda frondosa leaf paste in reduction of flakes on the scalp and reduction of itching.Timepoint: 1st, 2nd,and 4th week	—

Secondary

Measure	Time frame
Assessing whether there is remission of symptoms of darunaka or notTimepoint: 15days	—

Countries

India

Contacts

Public ContactDrShrikanthP

SDM College of Ayurveda,Hospital and Research Centre, Kuthpady, Udupi.

drshrikanth.acharya@gmail.com9008982227

Outcome results